MEI Pharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,776 | -86 | -85 | |
EBITDA | -8,352 | -7,737 | -9,743 | -11,930 |
EBIT | -8,720 | -7,862 | -9,829 | -12,015 |
Net Income | -8,007 | -18,406 | -9,130 | -11,060 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,450 | -17,999 | -2,928 | -11,062 |
Cash | 6,952 | 3,705 | 2,368 | 5,174 |
Basic Shares | 6,663 | 6,663 | 6,660 | 6,660 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $65,297 | $48,816 | $40,697 | $25,535 |
Gross Profit | 64,914 | 47,001 | 39,462 | 24,127 |
EBITDA | 26,380 | -36,764 | -75,158 | -60,139 |
EBIT | 25,997 | -38,579 | -76,393 | -60,424 |
Net Income | 17,778 | -31,840 | -54,450 | -41,310 |
Net Change In Cash | 65,297 | 48,816 | 40,697 | 25,535 |
Cost of Revenue | -3,788 | |||
Free Cash Flow | -50,480 | -52,519 | -49,225 | -32,672 |
Cash | 3,705 | 16,906 | 15,740 | 8,543 |
Basic Shares | 6,663 | 6,660 | 6,260 | 5,720 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.20 |
2024-06-30 | -$2.76 |
2024-03-31 | -$1.37 |
2023-12-31 | -$1.66 |
